Patent assignee · CH · COMPANY

ZLB Behring AG

15Patents
1Active
15Granted
33Portfolio score

Filing activity: Jun 2, 1995 → Sep 14, 2012

Most-cited patents

PatentTitleAreaCited byStatus
US7045601B2 Storage-stable, liquid fibrinogen formulation Human Necessities 37 Expired
US7276235B2 Tissue glue with improved antiadhesive properties Human Necessities 32 Expired
US6874657B2 Biological sealant storage and dispensing system Human Necessities 31 Expired
US8906368B2 Immunoglobulin preparations having increased stability Human Necessities 12 Active
US7919592B2 Method for separating off viruses from a protein solution by means of nanofiltration Human Necessities 11 Expired
US6884616B1 DNA-construct for the tissue-specific expression of a blood coagulation factor Chemistry; Metallurgy 7 Expired
US7202065B2 Stabilized liquid preparation of the protease which activates blood coagulation factor VII, or of its proenzyme Human Necessities 6 Expired
US6831086B1 Process for the inactivation of viruses with the aid of acridine derivatives Chemistry; Metallurgy 5 Expired
US7053049B2 Method for treating unstable angina pectoris Human Necessities 4 Expired
US7038020B1 Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use Emerging Cross-Sectional Technologies 4 Expired
US6998388B1 High density lipoprotein against organ dysfunction following haemorrhagic shock Human Necessities 4 Expired
US6911334B2 Protease for activating clotting factor VII Physics 2 Expired
US7399471B2 Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use Emerging Cross-Sectional Technologies 0 Expired
US7220556B1 Preparation of factor XIIIa by gene manipulation Physics 0 Expired
US6835817B2 Monoclonal antibody which is specific for activated coagulation factor VII, and its use Chemistry; Metallurgy 0 Expired

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.